Calendar Merck KGaA OTC Markets

Equities

MKKGY

US5893392093

Market Closed - OTC Markets 01:29:59 08/06/2024 am IST 5-day change 1st Jan Change
36.98 USD -0.99% Intraday chart for Merck KGaA +1.85% +15.82%

Chart calendar Merck KGaA

a5f4cb.hS9ZJq81ZbJkdkg4ld3Wc2Td5DXsOWI3Ge328m13gZs.9GQdR_xRFOsxPDtq3Yi5PFLkqH_celMDcKfBghwR5fnGGWxO_Bhc9hIGEQ~2652e58830852d20436f2a39e00a2b7b

Upcoming events on Merck KGaA

01/08/2024 Q2 2024 Earnings Call
01/08/2024 10:30 am Q2 2024 Earnings Release
17/10/2024 Capital Markets Day
14/11/2024 Q3 2024 Earnings Call
14/11/2024 11:30 am Q3 2024 Earnings Release
06/03/2025 Q4 2024 Earnings Release (Projected)
14/05/2025 Q1 2025 Earnings Release (Projected)
31/07/2025 Q2 2025 Earnings Release (Projected)
13/11/2025 Q3 2025 Earnings Release (Projected)

Past events on Merck KGaA

04/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No - 8575
03/06/2024 08:42 pm American Society of Clinical Oncology Meeting - Abstract No - 4508
03/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No - 3018
03/06/2024 06:30 pm R&D Day
02/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No - 4567
02/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No - 4566
02/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No - TPS6126
02/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No - LBA3559
02/06/2024 12:00 am American Society of Clinical Oncology Meeting - Abstract No - 3550
01/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No - 2614
01/06/2024 07:30 pm American Society of Clinical Oncology Meeting - Abstract No - 2612
01/06/2024 01:30 pm American Society of Clinical Oncology Meeting - Abstract No - 3000
31/05/2024 American Society of Clinical Oncology Meeting - Abstract No - e18039
15/05/2024 05:30 pm Q1 2024 Earnings Call
15/05/2024 10:30 am Q1 2024 Earnings Release
29/04/2024 Détachement de for final dividend
26/04/2024 01:30 pm Annual General Meeting
07/03/2024 06:30 pm Q4 2023 Earnings Call
07/03/2024 11:30 am Q4 2023 Earnings Release
08/01/2024 10:30 pm JPMorgan Healthcare Conference

Past dividends on Merck KGaA

29/04/2024 Annual 2.2 EUR
02/05/2023 Annual 2.2 EUR
25/04/2022 Annual 1.85 EUR
26/04/2021 Annual 1.4 EUR
29/05/2020 Annual 1.3 EUR
29/04/2019 Annual 1.25 EUR
30/04/2018 Annual 1.25 EUR
02/05/2017 Annual 1.2 EUR
02/05/2016 Annual 1.05 EUR
20/04/2015 Annual 1 EUR

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Million EUR
Released
Forecast
Spread
16 152
16 092
0.37%
17 534
17 407
0.73%
19 687
19 632
0.28%
22 232
22 259
-0.12%
20 993
21 026
-0.16%

21 324

EBITDA
Million EUR
Released
Forecast
Spread
4 385
4 335
1.15%
5 201
5 081
2.36%
6 103
6 096
0.12%
6 849
6 898
-0.71%
5 879
5 823
0.97%

5 943

EBIT
Million EUR
Released
Forecast
Spread
2 120
2 262
-6.29%
2 985
2 985
-0.01%
4 179
4 150
0.69%
4 474
4 933
-9.29%
3 609
3 730
-3.24%

4 033

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread
1 735
1 928
-9.99%
2 630
2 726
-3.52%
3 924
3 886
0.97%
4 287
4 727
-9.3%
3 484
3 695
-5.72%

3 817

Net income
Million EUR
Released
Forecast
Spread
1 320
1 448
-8.85%
1 987
1 999
-0.57%
3 055
2 986
2.3%
3 326
3 674
-9.48%
2 824
2 831
-0.26%

2 997

EPS
EUR
Released
Forecast
Spread
3,04
3,36
-9.47%
4,57
4,62
-1.11%
7,03
6,89
2.1%
7,65
8,46
-9.54%
6,49
6,50
-0.22%

6,88

Announcement Date05/03/2004/03/2103/03/2202/03/2307/03/24-

Quarterly results

Fiscal PeriodDecember 2020 S1 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales
Million EUR
Released
Forecast
Spread
8 489
8 553
-0.75%
5 198
5 218
-0.38%
5 568
5 417
2.79%
5 806
5 695
1.95%
5 660
5 698
-0.66%
5 293
5 254
0.73%
5 302
5 221
1.55%
5 173
5 255
-1.56%
5 225
5 248
-0.44%
5 120
5 144
-0.47%

5 262


5 415


5 547

EBITDA
Million EUR
Released
Forecast
Spread
2 256
2 232
1.06%
1 629
1 631
-0.15%
1 782
1 709
4.27%
1 811
1 795
0.85%
1 628
1 658
-1.83%
1 587
1 550
2.41%
1 553
1 511
2.76%
1 446
1 369
5.66%
1 293
1 256
2.95%
1 454
1 354
7.38%

1 428


1 513


1 695

EBIT
Million EUR
Released
Forecast
Spread



1 173
1 198
-2.07%
1 177
1 248
-5.66%
1 234
1 319
-6.45%
890
1 241
-28.29%
1 035
1 124
-7.95%
969
1 028
-5.7%
983
903
8.89%
621
750
-17.18%
931
815
14.21%

833


1 078


1 086

Earnings before Tax (EBT)
Million EUR
Released
Forecast
Spread



1 139
1 131
0.74%
1 122
1 207
-7.05%
1 187
1 266
-6.26%
839
1 202
-30.19%
1 012
1 088
-7.01%
894
981
-8.88%
937
850
10.29%
641
839
-23.56%
899
785
14.55%

807


1 053


1 063

Net income
Million EUR
Released
Forecast
Spread



880
880
0.02%
867
931
-6.86%
923
980
-5.76%
655
967
-32.26%
796
825
-3.53%
704
765
-8%
739
658
12.37%
586
647
-9.4%
694
657
5.6%

699


824


875

EPS
EUR
Released
Forecast
Spread
1,72
1,86
-7.53%
2,02
2,02
-0.16%
1,99
2,13
-6.65%
2,12
2,27
-6.43%
1,51
2,22
-32.06%
1,83
1,90
-3.6%
1,62
1,76
-8.06%
1,70
1,54
10.21%
1,34
1,50
-10.42%
1,60
1,52
5.02%

1,60


1,91


2,02

Announcement Date06/08/2012/05/2204/08/2210/11/2202/03/2311/05/2303/08/2309/11/2307/03/2415/05/24---

Net sales - Quarter - Rate of surprise

Quarterly earnings - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise